论文部分内容阅读
目的:分析探讨哺乳期子宫放环术中出血的临床治疗方法与疗效。方法:选取98例哺乳期子宫放环术妇女为研究对象,随机分为对照组与实验组,各49例,对照组妇女在术前给予宫缩素,实验组术后给予葆宫止血颗粒治疗,观察两组的术后出血情况、月经量以及其他不良反应情况。结果:实验组术后3个月出血18.4%,显著低于对照组42.9%(P<0.01);治疗后月经量比术后显著下降(P<0.05)。实验组不良反应发生率16.3%,显著低于对照组44.9%(P<0.01)。结论:给予哺乳期子宫放环术中出血患者术后葆宫止血颗粒治疗,可有效减少术后出血的发生,减少放环术后月经量,安全可靠,具有临床推广应用的价值。
Objective: To analyze and discuss the clinical treatment and curative effect of hemorrhage in lactating uterine bleeding. Methods: A total of 98 cases of lactating women with uterine bleeding were enrolled in this study. They were randomly divided into control group and experimental group, 49 cases in each group. Women in control group were treated with orifacient preoperatively. The postoperative bleeding, menstrual flow and other adverse reactions were observed in both groups. Results: The bleeding in experimental group was 18.4% at 3 months after operation, which was significantly lower than that in control group (42.9%, P <0.01). The amount of menstruation after operation was significantly lower than that after operation (P <0.05). The incidence of adverse reactions in the experimental group was 16.3%, which was significantly lower than that in the control group (44.9%, P <0.01). Conclusion: It is safe and reliable to treat postoperative bleeding by giving BaoGong hemostatic granule to patients after hemorrhage in lactating uterine bleeding. It has the value of clinical popularization and application.